1. Home
  2. RUN vs IRON Comparison

RUN vs IRON Comparison

Compare RUN & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunrun Inc.

RUN

Sunrun Inc.

HOLD

Current Price

$9.59

Market Cap

3.0B

Sector

Miscellaneous

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$78.02

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RUN
IRON
Founded
2007
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.9B
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
RUN
IRON
Price
$9.59
$78.02
Analyst Decision
Buy
Strong Buy
Analyst Count
20
11
Target Price
$18.80
$103.18
AVG Volume (30 Days)
9.7M
492.5K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
113.35
N/A
EPS
0.62
N/A
Revenue
$858,578,000.00
N/A
Revenue This Year
$2.81
N/A
Revenue Next Year
$4.54
$283.52
P/E Ratio
$15.35
N/A
Revenue Growth
12.97
N/A
52 Week Low
$9.01
$40.00
52 Week High
$22.44
$99.50

Technical Indicators

Market Signals
Indicator
RUN
IRON
Relative Strength Index (RSI) 25.14 48.40
Support Level N/A $70.29
Resistance Level $13.46 $82.65
Average True Range (ATR) 0.62 3.35
MACD -0.24 -0.48
Stochastic Oscillator 5.20 25.06

Price Performance

Historical Comparison
RUN
IRON

About RUN Sunrun Inc.

Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: